Related Experiment Video
Updated: May 16, 2026

04:10
Robotic-assisted Bronchoscopy Combined with Multimodal Imaging for Targeted Lung Cryobiopsies
Published on: July 19, 2024
Imaging bronchogenic adenocarcinoma: emerging concepts
Adam Wallis1, Ladli Chandratreya, Nidhi Bhatt
1Severn School of Radiology, Bristol, UK.
Journal of Computer Assisted Tomography
|November 30, 2012
Summary
The revised lung adenocarcinoma classification replaces bronchoalveolar carcinoma with new categories for invasive and preinvasive lesions. This update will likely influence future World Health Organization and TNM classifications for lung cancer.
Area of Science:
- Pulmonology
- Oncology
- Radiology
Background:
- Recent advances in understanding lung adenocarcinoma have necessitated a revised classification.
- The new classification replaces the term bronchoalveolar carcinoma.
Purpose of the Study:
- To introduce the concepts of preinvasive, minimally invasive, and frankly invasive lesions in lung adenocarcinoma.
- To illustrate the radiographic appearance of these new classifications.
- To provide guidance on the management of lung adenocarcinoma based on the revised classification.
Main Methods:
- Review of current literature and expert consensus on lung adenocarcinoma classification.
- Radiographic analysis of lesions corresponding to the new classification categories.
- Development of management strategies based on lesion characteristics.
Main Results:
- The revised classification introduces distinct categories for preinvasive, minimally invasive, and frankly invasive lung adenocarcinoma.
- Specific radiographic features are associated with each lesion type.
- Management guidelines are proposed based on the new classification.
Conclusions:
- The revised lung adenocarcinoma classification offers a more precise framework for diagnosis and management.
- These concepts are expected to be integrated into future World Health Organization and TNM classifications.
- Further validation is required, but the classification provides a valuable tool for clinicians.